Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Iobenguane I-131 - Jubilant DraxImage

Next Previous
Drug Profile

Iobenguane I-131 - Jubilant DraxImage

Alternative Names: 131I-metaiodobenzylguanidine; 131I-MIBG; I-131 meta-iodobenzylguanidine; Iobenguane I-131 MIBG; Iobenguane sulfate; m-Iodobenzylguanidine sulfate

Latest Information Update: 01 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jubilant DraxImage
  • Developer Jubilant DraxImage; New Approaches to Neuroblastoma Therapy Consortium; University Hospital Southampton NHS Foundation Trust
  • Class Antineoplastics; Guanidines; Imaging agents; Iodobenzenes; Radiopharmaceutical diagnostics; Small molecules; Sulfates
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Neuroblastoma

Most Recent Events

  • 23 Feb 2024 New Approaches to Neuroblastoma Therapy Consortium completes a phase I trial in Neuroblastoma (Combination therapy, In adults, In adolescents, In children, In infants, Second-line therapy or greater) in USA (IV) (NCT03332667)
  • 03 Jun 2022 Updated clinical data from a phase II trial in Neuroblastoma (In infants, In children, In adolescents, In adults, Second-line therapy or greater, Monotherapy) presented at the 58th Annual Meeting of the American Society of Clinical Oncology (ASCO-2022)
  • 28 Jun 2021 No recent reports of development identified for phase-I development in Neuroblastoma(In adolescents, In children, In infants, Second-line therapy or greater, In adults) in United Kingdom (IV, Infusion)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top